Related Experiment Video

Updated: Jun 22, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b

Yosuke Mizuno1, Yoshimi Tokuzawa, Yuichi Ninomiya

  • 1Division of Functional Genomics and Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Japan.

FEBS Letters
|June 13, 2009
PubMed

Insights

MicroRNA-210 (miR-210) promotes osteoblastic differentiation by inhibiting the TGF-beta/activin pathway. This study reveals miR-210

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Stem Cell Biology

Background:

  • MicroRNAs (miRNAs) regulate diverse biological processes, but their role in osteoblastic differentiation remains unclear.
  • Osteoblastic differentiation is crucial for bone formation and remodeling.

Purpose of the Study:

  • To elucidate the role of microRNA-210 (miR-210) in regulating osteoblastic differentiation.
  • To identify the molecular targets and signaling pathways modulated by miR-210 during osteogenesis.

Main Methods:

  • Transfection of sense and antisense miR-210 into bone marrow-derived ST2 stromal cells.
  • Reporter assays to validate gene targets of miR-210.
  • Pharmacological inhibition of transforming growth factor-beta (TGF-beta)/activin signaling.

Main Results:

  • BMP-4-induced osteoblastic differentiation was enhanced by sense miR-210 and repressed by antisense miR-210.
  • The activin A receptor type 1B (AcvR1b) gene was identified as a direct target of miR-210.
  • Inhibition of TGF-beta/activin signaling using SB431542 promoted osteoblastic differentiation in ST2 cells.

Conclusions:

  • miR-210 positively regulates osteoblastic differentiation.
  • miR-210 exerts its function by inhibiting the TGF-beta/activin signaling pathway via targeting AcvR1b.

More Related Videos

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts07:13

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts

Published on: May 13, 2014

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...